Hye Jin Jung Selected Research

Hye Jin Jung Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 02/2007
20	Hypoxia (Hypoxemia) 03/2021 - 04/2010
10	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 05/2015
5	Stomach Neoplasms (Stomach Cancer) 03/2023 - 08/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 08/2018
3	Melanoma (Melanoma, Malignant) 04/2020 - 07/2016
2	Leukemia 01/2024 - 04/2021
2	Neoplasm Metastasis (Metastasis) 09/2023 - 10/2016
2	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 06/2020
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2018
2	Carcinogenesis 02/2011 - 01/2010
2	Corneal Neovascularization 12/2007 - 02/2007
1	Multiple Myeloma 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Triple Negative Breast Neoplasms 09/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023
1	Adenocarcinoma 03/2021
1	Carcinoma (Carcinomatosis) 07/2020
1	Inflammation (Inflammations) 03/2019
1	Liver Neoplasms (Liver Cancer) 08/2018
1	Tuberculosis (Tuberculoses) 07/2016

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 08/2010
7	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021 - 04/2010
5	Angiogenesis InhibitorsIBA 01/2021 - 02/2011
4	Carrier Proteins (Binding Protein)IBA 01/2018 - 02/2011
4	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 10/2014 - 04/2010
3	Cyclophilin AIBA 05/2023 - 03/2021
3	terpestacinIBA 01/2023 - 04/2010
2	IntegrinsIBA 01/2024 - 09/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2020
2	berbamine (penduline)IBA 11/2022 - 01/2021
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2022 - 10/2021
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 03/2022 - 01/2019
2	Caspase 3 (Caspase-3)IBA 04/2021 - 03/2019
2	ampelopsinIBA 04/2021 - 12/2017
2	alizarinIBA 07/2020 - 08/2018
2	ResveratrolIBA 01/2020 - 07/2016
2	Melanocyte-Stimulating Hormones (MSH)IBA 03/2019 - 07/2016
2	GlucosidesIBA 08/2018 - 04/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2015
1	furamidine (DB75)IBA 03/2024
1	Natalizumab (Tysabri)FDA Link 01/2024
1	Cysteine (L-Cysteine)FDA Link 01/2024
1	Integrin alpha4beta1 (VLA-4)IBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	bufotalinIBA 09/2023
1	Amino Acids FDA Link 01/2023
1	1,4-dihydroxyanthraquinone (quinizarin)IBA 12/2022
1	arcyriaflavin AIBA 11/2022
1	Mevalonic Acid (Mevalonate)IBA 09/2022
1	Phosphotransferases (Kinase)IBA 09/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2022
1	CateninsIBA 09/2022
1	Aldehyde DehydrogenaseIBA 09/2022
1	Sorafenib (BAY 43-9006)FDA Link 09/2022
1	Atorvastatin (Lipitor)FDA Link 09/2022
1	violaceinIBA 10/2021
1	tamarixetinIBA 06/2021
1	QuercetinIBA 06/2021
1	Caspase 9IBA 04/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2021
1	CyclinsIBA 04/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2021
1	nargenicin A1IBA 03/2021
1	CaspasesIBA 03/2021
1	Chloroform (Trichloromethane)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	mangostinIBA 06/2020
1	GlycosidesIBA 06/2020
1	Death Domain ReceptorsIBA 04/2020
1	beauvericinIBA 04/2020
1	pterostilbeneIBA 01/2020
1	Peptides (Polypeptides)IBA 03/2019
1	Bee Venoms (Bee Venom)IBA 03/2019
1	Melanins (Melanin)IBA 03/2019
1	Melitten (Melittin)IBA 03/2019
1	Temozolomide (Temodar)FDA LinkGeneric 03/2019
1	ImmunosorbentsIBA 03/2019
1	EnzymesIBA 03/2019
1	hydrazinobenzoylcurcuminIBA 01/2019
1	CurcuminIBA 01/2019
1	elaiophylinIBA 03/2018
1	ubiquinolIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	20- O- (beta- D- glucopyranosyl)- 20(S)- protopanaxadiolIBA 08/2017
1	ApigeninIBA 11/2016
1	tricinIBA 10/2016
1	InterferonsIBA 07/2016
1	alpha-MSHIBA 07/2016
1	Adenosine Monophosphate (AMP)IBA 07/2016
1	flavoneIBA 07/2016
1	Microphthalmia-Associated Transcription FactorIBA 07/2016
1	6,7-dihydroxyflavoneIBA 07/2016

Therapy/Procedure

10	Therapeutics 01/2024 - 02/2011
3	Drug Therapy (Chemotherapy) 04/2021 - 11/2016
2	Radiotherapy 04/2021 - 11/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2021
1	Complementary Therapies (Alternative Medicine) 01/2021